Drugs / Sodium Pentaborate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05798455 | May 2023 → May 2025 | renal cell carcinoma | Tabriz University of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Pentaborate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05798455 ↗ |
| Known as | Sodium borate (nab5o8) | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314999 ↗ |
| Route | Oral | “One oral sodium pentaborate pentahydrate capsule once daily” NCT05798455 ↗ |